The viscosupplementation market in the United States involves products that are injected into the knee joint of patients suffering from osteoarthritis. Viscosupplementation involves the use of hyaluronic acid injections to supplement the viscosity of the synovial fluid in the knee joint. The products aim to reduce pain and improve mobility in patients suffering from knee osteoarthritis. The market has seen increased adoption owing to the advantages such as minor side effects and reduced risks associated with surgery for osteoarthritis patients.

The United States of America Viscosupplementation Market is estimated to be valued at USD 1.54 Bn in 2024 and is expected to reach USD 2.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Key players operating in the United States viscosupplementation market are Johnson & Johnson, F. Hoffmann-La Roche AG, Zimmer Biomet, Sanofi S.A., and Anika Therapeutics Inc.

The growing prevalence of knee osteoarthritis in the United States of America Viscosupplementation Market is a major factor driving the demand for viscosupplementation therapies. According to estimates, over 30 million Americans suffer from osteoarthritis with over 13 million having osteoarthritis only in the knees. The condition is more common among the geriatric population in the country.

Technological advancements are being made to develop more effective hyaluronic acid formulations that can last longer in the knee joint providing relief for longer periods and reducing the need for multiple injections. Companies are working on formulations that can give relief for 6 months to an year with a single injection.

Market Trends
Increasing Obesity Levels - The rising incidence of obesity has been linked to the higher risk of developing osteoarthritis. As the United States battles high obesity rates, the requirement for arthritis treatments like viscosupplementation is surging.

Preference for Minimally Invasive Treatments - Patients prefer viscosupplementation over other therapies due to the minimally invasive nature, lower risks of side effects, and quicker recovery. This is a major factor leading to increased adoption.

Market Opportunities
Single Injection Long-Lasting Formulations - Companies are researching novel formulations that can provide relief from a single injection for 6 months to 1 year. This could drive higher preference and adherence.

Approvals for New Indications - New clinical studies evaluating use in disorders like shoulder osteoarthritis can lead to new treatment opportunities and approvals.

Impact of COVID-19 on United States of America Viscosupplementation Market Growth
The COVID-19 pandemic has negatively impacted the growth of the United States of America viscosupplementation market during the forecast period. In the initial months of the pandemic, lockdowns and restrictions reduced access to non-emergency medical services including orthopedic procedures. This led to decline in demand for viscosupplementation products during 2020 and 2021. With delay in non-urgent surgeries and procedures, manufacturers witnessed reduced sales volumes.

Pre-pandemic, the market was growing steadily owing to rising geriatric population suffering from osteoarthritis, growing awareness about viscosupplementation therapy and its advantages over other treatments. However, COVID-19 brought short term decline and long term uncertainties. Post-pandemic, the market is expected to pick up pace again due to pent up demand from delayed procedures during the peak pandemic period.

Geographical Concentration of United States of America Viscosupplementation Market
In terms of value, the Western region accounts for the largest share in the United States viscosupplementation market currently. States like California, Washington and Oregon have higher burden of osteoarthritis due to older population demographics and lifestyle factors. For instance, more than 30% of the population in the Western states is above 65 years of age which is the major risk group for joint disorders. Second largest region is North Central region comprising states like Illinois, Indiana, Iowa and Michigan among others. Availability of advanced healthcare infrastructure and greater awareness level among consumers have been driving the market growth in these regions.

Fastest Growing Region in United States of America Viscosupplementation Market
The Southern region of the United States encompassing states like Texas, Florida, North Carolina and Georgia is projected to be the fastest growing market for viscosupplementation during the forecast period. Obesity rates are highest in the Southern states which is a key contributor to osteoarthritis cases. Moreover, greater focus of market players on expanding presence,rising medical tourism and improving access to non-invasive treatments in the region will support market growth. States like Texas and Florida are witnessing rapid population aging which is expanding the target patient pool.

Get more insights on: United States of America Viscosupplementation Market

Get this Report in Japanese Language: アメリカ合衆国の粘性補充市場

Get this Report in Korean Language: 미국 점액 보충 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)